Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2013121215765N1Phase 3Completed
Phase 3 trial of metformin in prediabetes and thyroid disease (2 arms), sponsored by Isfahan Endocrine and Metabolism Research Center. Primary endpoints: TSH change and Thyroid volume change. Started Apr 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2013121215765N1.